Lipopolysaccharide and tumor necrosis factor-α synergy potentiate serum-dependent responses of rat macrophages

Shock

Volumn 5, Issue 6, 1996, Pages 429-433

  Fox, Eben S ^a,b   Wang, Lei ^a   Tracy Jr , Thomas F ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; NORTHERN BLOTTING; PATHOPHYSIOLOGY; RAT; SEPSIS; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, NORTHERN; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030156246     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199606000-00007     Document Type: Article

References (22)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431-1433,1990.
2. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ: Plasma lipopolysaccharide (LPS)-binding protein: A key component in macrophage recognition of Gram-negative LPS. J Immunol 149:200-206,1992.
3. Ulevitch RJ, Tobias PS: Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 13:437-457, 1995.
4. Tobias P, Soldau K, Ulevitch RJ: Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 164:777-793,1986.
5. Geller DA, Kispert PH, Su GL, et al: Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute phase response. Arch Surg 128:22-28, 1993.
6. Wan Y, Freeswick PD, Khemlani LS, et al: Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats. Infect Immun 63:2435-2442, 1995.
7. Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP: Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 90:9935-9938, 1993.
8. Lauener RP, Goyert SM, Geha RS, Vercelli D: Interleukin 4 downregulates the expression of CD14 in normal human monocytes. Eur J Immunol 20:2375-2381, 1990.
9. 1 lowers the CD14 content of monocytes. J Surg Res 57:574-578, 1994.
10. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA: Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14. J Exp Med 173:1281-1286, 1991.
11. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci USA 85:607-611, 1988.
12. Tracy TF Jr, Fox ES: CD14-lipopolysaccharide receptor activity in hepatic macrophages after cholestatic liver injury. Surgery 118:371-377, 1995.
13. Brown CW, McHugh KM, Lessard JL: A cDNA sequence encoding cytoskeletal gamma actin from rat. Nucleic Acids Res 18:5312, 1990.
14. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A: Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670-1674, 1986.
15. Fox ES, Tracy TF Jr: Alterations in TNF-α expression by hepatic macrophages following acute cholestatic liver injury. Shock 5:112-115, 1996.
16. Parrillo JE: Pathogenic mechanisms of septic shock. N Engl J Med 328:1471-1477, 1993.
17. Zanetti G, Glauser MP, Baumgartner JD: Anti-endotoxin antibodies and other inhibitors of endotoxin. New Horizons 1:110-126, 1993.
18. Pruitt JH, Copeland EM, Moldawer LL: Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock 3:235-251, 1995.
19. Van der Poll T, Lowry SF: Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense? Shock 3:1-12, 1995.
20. 23) decreases Escherichia coli-induced mortality and organ injury during immunosuppression-related neutropenia. Shock 4:298-306, 1995.
21. Dentener MA, Von Asmuth EJU, Francot GJM, Marra MN, Buurman WA: Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. J Immunol 151:4258-4265, 1993.
22. Gallay P, Heumann D, Le Roy D, Glauser MP: Mode of action of anti-lipopolysaccharide binding protein antibodies for prevention of endotoxemic shock in mice. Proc Natl Acad Sci USA 91:7922-7926, 1994.